|
Other anticoagulants
Citations 1-10 of 27 total displayed.
|
Most recent content
(1 May 2008):
|
- Original Contributions
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
- Jeff S. Healey, Robert G. Hart, Janice Pogue, Marc A. Pfeffer, Stefan H. Hohnloser, Raffaele De Caterina, Greg Flaker, Salim Yusuf, and Stuart J. Connolly
Stroke 39: 1482 -1486; published online before print as doi:10.1161/STROKEAHA.107.500199
[Abstract]
[Full text]
|
Past content
(since Nov 2000):
|
- Cochrane Corner
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks
- Maria I. Aguilar and Robert Hart
Stroke 39: 1399 -1400; published online before print as doi:10.1161/STROKEAHA.107.500363
[Full text]
- Articles
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks
- Maria I. Aguilar and Robert Hart
Stroke published March 6, 2008, doi:10.1161/STROKEAHA.107.500363
[Abstract]
- Articles
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk. The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
- Jeff S. Healey, Robert G. Hart, Janice Pogue, Marc A. Pfeffer, Stefan H. Hohnloser, Raffaele De Caterina, Greg Flaker, Salim Yusuf, and Stuart J. Connolly
Stroke published March 6, 2008, doi:10.1161/STROKEAHA.107.500199
[Abstract]
- Original Contributions
Direct Thrombin Inhibition and Stroke Prevention in Elderly Patients With Atrial Fibrillation: Experience From the SPORTIF III and V Trials
- Gary A. Ford, Anna Maria Choy, Prakash Deedwania, Dean G. Karalis, Carl-Johan Lindholm, Wladyslaw Pluta, Lars Frison, S. Bertil Olsson on behalf of the SPORTIF III, V Investigators
Stroke 38: 2965 -2971; published online before print as doi:10.1161/STROKEAHA.107.488007
[Abstract]
[Full text]
- Articles
Direct Thrombin Inhibition and Stroke Prevention in Elderly Patients With Atrial Fibrillation. Experience From the SPORTIF III and V Trials
- Gary A. Ford, Anna Maria Choy, Prakash Deedwania, Dean G. Karalis, Carl-Johan Lindholm, Wladyslaw Pluta, Lars Frison, S. Bertil Olsson SPORTIF III, V Investigators
Stroke published September 20, 2007, doi:10.1161/STROKEAHA.107.488007
[Abstract]
- Editorials
Predicting Stroke Risk in Patients With Atrial Fibrillation
- Daniel G. Hackam
Stroke 38: 2409 ; published online before print as doi:10.1161/STROKEAHA.107.488114
[Full text]
- Original Contributions
Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
- Lawrence Baruch, Brian F. Gage, Jay Horrow, Steen Juul-Möller, Arthur Labovitz, Maria Persson, and Miguel Zabalgoitia
Stroke 38: 2459 -2463; published online before print as doi:10.1161/STROKEAHA.106.477133
[Abstract]
[Full text]
- Articles
Predicting Stroke Risk in Patients With Atrial Fibrillation
- Daniel G. Hackam
Stroke published August 2, 2007, doi:10.1161/STROKEAHA.107.488114
[Abstract]
- Articles
Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
- Lawrence Baruch, Brian F. Gage, Jay Horrow, Steen Juul-Möller, Arthur Labovitz, Maria Persson, and Miguel Zabalgoitia
Stroke published August 2, 2007, doi:10.1161/STROKEAHA.106.477133
[Abstract]
|
|
